NIA readies to quiz Vaidik; RSS leader calls him a nationalist

July 17, 2014

hafeez vaidik

New Delhi, Jul 17: On a day when RSS leader Indresh Kumar spoke out in support of Ved Pratap Vaidik's controversial interaction with Jamaat-ud-Dawa (JuD) chief, home ministry sources indicated that the Baba Ramdev aide could be soon questioned by the National Investigation Agency in connection with the 26/11 investigations.

Kumar, who heads BJP's Muslim outreach programme, on Wednesday told a TV news agency, "I have seen media reports. A journalist is at liberty to meet anyone he wishes to. Vaidikji is deeply rooted in culture and is a nationalist. Whatever he did he must have done keeping in mind national interest."

Kumar's statement comes at a time when the government has condemned Vaidik's meeting with Saeed and and rebutted the insinuation that it may have been in the know of the journalist's engagements in Pakistan.

Kumar, however, denied that Vaidik was involved with RSS as alleged by Congress vice president Rahul Gandhi on Tuesday. Vaidik himself has denied that he is an RSS man.

That Vaidik is a close aide of yoga guru Ramdev has led NDA's opponents to allege that the interaction may have been arranged by the BJP-led government.

Kumar was last in the news over investigations into his links with Hindu terrorists who allegedly carried out the Samjhauta train blasts.

Sources in the home ministry say Vaidik could be questioned to know how he got access to Saeed, what he said and what he had gathered of the terror mastermind as a person. Sources said Vaidik might be questioned as a witness in connection with 26/11 investigations, but may be treated as an accused later if something adverse comes up about his meeting with Saeed.

Under law, an investigation agency can question anyone who has had an interaction with an absconding accused. NIA has been investigating the Mumbai attacks and has questioned Pakistan-born US citizen David Coleman Headley. In the case of Vaidik even Mumbai Crime Branch, which is also investigating the case, would have the right to call him for questioning.

A senior home ministry official said, "Vaidik should be questioned on how he managed to get access to Hafiz Saeed. NIA has the right to question him and a decision on this would be taken in due course. If nothing, the agency would like to know what Saeed said about various things, what are his plans, if any revealed, and what kind of a person he is. This would be valuable to investigations. He could be treated as witness as of now, but could turn an accused if something adverse is found."

Sources said Vaidik's interaction with Saeed is important as he is the only person in India outside of Kashmir who has had a one-on-one interaction with Saeed.

The Mumbai police readily sends summons to journalists who receive phone calls from underworld dons such as Dawood Ibrahim aide Chhota Shakeel and Chhota Rajan and records statements. "Here Vaidik has had an interaction in Pakistan. It's very important," said an investigator.

Meanwhile, a case of sedition was filed against Vaidik in a Varanasi court by a local lawyer. The court has posted it for hearing on July 25.

Vaidik's visit to Pakistan and his subsequent interaction with Hafiz Saeed as a "journalist" has been called into question as the "interview" has not been published anywhere. It is not known whether as a "journalist", Vaidik asked Saeed about his involvement in 26/11 attacks and various other attacks.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 27,2020

New Delhi, Jan 27: The government on Monday issued the preliminary information memorandum for 100 per cent stake sale in national carrier Air India. As part of the strategic disinvestment, Air India would also sell 100 per cent stake in low cost airline Air India Express and 50 per cent shareholding in joint venture AISATS, as per the bid document issued on Monday.

Management control of the airline would also be transferred to the successful bidder.

The government has set March 17 as the deadline for submitting the Expression of Interest (EoI).

EY is the transaction adviser for Air India disinvestment process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 11,2020

New Delhi, May 11: With an increase of 4,213 cases in the past 24 hours, India's COVID-19 count reached 67,152 on Monday, according to the Union Ministry of Health and Family Welfare.

The number of active cases in the country rose to 44,029, while 20,916 patients have been cured and discharged and one has migrated, according to the Ministry.

The number of deaths in the country due to the infection reached 2,206 on Sunday.

Maharashtra, with 22,171 confirmed cases is the worst-affected due to the infection so far and is followed by Gujarat with 8,194 cases.

However, Tamil Nadu surpassed the national capital in total coronavirus cases numbers. Delhi has 6,923 reported cases while Tamil Nadu has 7,204 confirmed cases.

Maximum deaths due to coronavirus have so far been recorded in Maharashtra (832), followed by Gujarat which has toll of 493.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.